CDH1/E-cadherin and solid tumors. An updated gene-disease association analysis using bioinformatics tools

被引:6
|
作者
Florencia Abascal, Maria [1 ]
Jose Besso, Maria [1 ]
Rosso, Marina [1 ]
Victoria Mencucci, Maria [1 ]
Aparicio, Evangelina [1 ]
Szapiro, Gala [1 ]
Ines Furlong, Laura [2 ]
Hebe Vazquez-Levin, Monica [1 ]
机构
[1] Fdn IBYME FIBYME, Lab Cell Cell Interact Canc & Reprod, Inst Biol & Med Expt IBYME, Consejo Nacl Invest Cient & Tecn CONICET, Vuelta Obligado 2490,Zip Code C1428ADN, Buenos Aires, DF, Argentina
[2] Univ Pompeu Fabra, DCEXS, Res Programme Biomed Informat GRIB IMIM, C Dr Aiguader 88, Barcelona 08003, Spain
关键词
CDHI; Epithelial Cadherin; Solid tumors; Bioinformatics; Somatic mutations; AMINO-ACID SUBSTITUTIONS; E-CADHERIN EXPRESSION; CELL-CELL ADHESION; SOMATIC MUTATIONS; PROMOTER HYPERMETHYLATION; MESENCHYMAL TRANSITION; DOWN-REGULATION; BREAST-CANCER; TEXT; CARCINOMA;
D O I
10.1016/j.compbiolchem.2015.10.002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer is a group of diseases that causes millions of deaths worldwide. Among cancers, Solid Tumors (ST) stand-out due to their high incidence and mortality rates. Disruption of cell-cell adhesion is highly relevant during tumor progression. Epithelial-cadherin (protein: E-cadherin, gene: CDHI) is a key molecule in cell-cell adhesion and an abnormal expression or/and function(s) contributes to tumor progression and is altered in ST. A systematic study was carried out to gather and summarize current knowledge on CDH1/E-cadherin and ST using bioinformatics resources. The DisGeNET database was exploited to survey CDHI-associated diseases. Reported mutations in specific ST were obtained by interrogating COSMIC and IntOGen tools. CDHI Single Nucleotide Polymorphisms (SNP) were retrieved from the dbSNP database. DisGeNET analysis identified 609 genes annotated to ST, among which CDHI was listed. Using CDHI as query term, 26 disease concepts were found, 21 of which were neoplasms-related terms. Using DisGeNET ALL Databases, 172 disease concepts were identified. Of those, 80 ST disease-related terms were subjected to manual curation and 75/80 (93.75%) associations were validated. On selected ST, 489 CDHI somatic mutations were listed in COSMIC and lntOGen databases. Breast neoplasms had the highest CDH1/mutation rate. CDHI was positioned among the 20 genes with highest mutation frequency and was confirmed as driver gene in breast cancer. Over 14,000 SNP for CDHI were found in the dbSNP database. This report used DisGeNET to gather/compile current knowledge on gene-disease association for CDH1/E-cadherin and ST; data curation expanded the number of terms that relate them. An updated list of CDHI somatic mutations was obtained with COSMIC and IntOGen databases and of SNP from dbSNP. This information can be used to further understand the role of CDHI/E-cadherin in health and disease. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 50 条
  • [41] The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility:: from the laboratory to clinical practice
    Graziano, F
    Humar, B
    Guilford, P
    ANNALS OF ONCOLOGY, 2003, 14 (12) : 1705 - 1713
  • [42] Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from Kashmir
    Asiaf, Asia
    Ahmad, Shiekh Tanveer
    Aziz, Sheikh Aejaz
    Malik, Ajaz Ahmad
    Rasool, Zubaida
    Masood, Akbar
    Zargar, Mohammad Afzal
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (15) : 6397 - 6403
  • [43] CDH1 (E-cadherin) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story
    Buecker, Lara
    Lehmann, Ulrich
    CANCERS, 2022, 14 (18)
  • [44] The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage
    Pannone, G.
    Santoro, A.
    Feola, A.
    Bufo, P.
    Papagerakis, P.
    Lo Muzio, L.
    Staibano, S.
    Ionna, F.
    Longo, F.
    Franco, R.
    Aquino, G.
    Contaldo, M.
    De Maria, S.
    Serpico, R.
    De Rosa, A.
    Rubini, C.
    Papagerakis, S.
    Giovane, A.
    Tombolini, V.
    Giordano, A.
    Caraglia, M.
    Di Domenico, M.
    CURRENT CANCER DRUG TARGETS, 2014, 14 (02) : 115 - 127
  • [45] Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
    Wheeler, JMD
    Kim, HC
    Efstathiou, JA
    Ilyas, M
    Mortensen, NJM
    Bodmer, WF
    GUT, 2000, 46 : A53 - A53
  • [46] Assignment of the E-cadherin gene (CDH1) to chromosome 16q22.1 by radiation hybrid mapping
    Huntsman, DG
    Caldas, C
    CYTOGENETICS AND CELL GENETICS, 1998, 83 (1-2): : 82 - 83
  • [47] The E-Cadherin (CDH1)-C160A Polymorphism and Colorectal Cancer Susceptibility: A Meta-Analysis
    Geng, Peiliang
    Chen, Yuying
    Ou, Juanjuan
    Yin, Xiaoling
    Sa, Rina
    Liang, Houjie
    DNA AND CELL BIOLOGY, 2012, 31 (06) : 1070 - 1077
  • [48] E-CADHERIN (CDH1) GENE-160C>A PROMOTER POLYMORPHISM AND RISK OF GASTRIC AND ESOPHAGEAL CANCERS
    Akbas, Halit
    Uyanikoglu, Ahmet
    Aydogan, Timucin
    Atay, Ahmet Engin
    Dilmec, Fuat
    Cerrah, Serkan
    Akkafa, Feridun
    Nar, Hasim
    ACTA MEDICA MEDITERRANEA, 2013, 29 (04): : 671 - 676
  • [49] Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes
    Frank Grünhage
    Matthias Jungck
    Christoph Lamberti
    Christine Berg
    Ursula Becker
    Hildegard Schulte-Witte
    Dominik Plassmann
    Nils Rahner
    Stefan Aretz
    Nicolaus Friedrichs
    Reinhard Buettner
    Tilman Sauerbruch
    Frank Lammert
    International Journal of Colorectal Disease, 2008, 23 : 147 - 154
  • [50] CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer
    Norton, Jeffrey A.
    Ham, Christine M.
    Van Dam, Jacques
    Jeffrey, R. Brooke
    Longacre, Teri A.
    Huntsman, David G.
    Chun, Nicki
    Kurian, Allison W.
    Ford, James M.
    ANNALS OF SURGERY, 2007, 245 (06) : 873 - 879